TY  - JOUR 
AU  - Troya, Jesús
AU  - Pedrero Tomé, Roberto
AU  - Buzón, Luis
AU  - Dueñas Gutiérrez, Carlos Jesús
PY  - 2023
SN  - 2077-0383
UR  - https://uvadoc.uva.es/handle/10324/63487
AB  - Background: Immune recovery in people living with HIV (PLWHIV) is a residual aspect of antiretroviral treatment (ART) in most patients, but in a non-negligible proportion of them, the CD4+ lymphocytes count, or CD4/CD8 ratio remains suboptimal....
LA  - eng
PB  - MDPI
KW  - HIV
KW  - HIV infections
KW  - VIH
KW  - Infecciones por VIH
KW  - AIDS (Disease)
KW  - Sida
KW  - Infectious diseases
KW  - Immunology
KW  - Medicine
KW  - Public health
KW  - Dolutegravir
KW  - Lamivudine
TI  - Predict the effects of dolutegravir (DTG) plus lamivudine (3TC) on immunological responses in people living with HIV (PLWHIV)
DO  - 10.3390/jcm12031176
ER  -